Literature DB >> 3055577

Metastatic patterns in osteosarcoma.

G Bacci1, M Avella, P Picci, A Briccoli, D Dallari, M Campanacci.   

Abstract

The clinical courses of 193 patients with high-grade, non-metastatic osteosarcoma were reviewed to ascertain the evolution of the natural history of the disease. All patients had the primary lesion in the extremities and were treated at the Rizzoli Orthopaedic Institute between 1976 and 1982 with surgery alone (30 cases) or surgery plus adjuvant chemotherapy (163 cases). All patients were regularly followed at our Institute. One hundred and fourteen patients, of which 27 were treated with surgery alone and 87 treated with adjuvant chemotherapy, developed overt metastatic disease. No differences were found concerning the sites of the first relapse which, for approximately 90% of cases, were lungs in both groups. However, in the group of patients treated with adjuvant chemotherapy the development of overt metastatic disease, as compared to non-adjuvant patients, was delayed with time (13 vs 8 months) and the number of metastatic nodules in the lung at first relapse was reduced. This alteration in metastatic pattern due to adjuvant chemotherapy is important because it allows surgical resection of pulmonary metastases in a larger number of patients (51% vs 29%).

Entities:  

Mesh:

Year:  1988        PMID: 3055577     DOI: 10.1177/030089168807400408

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

1.  Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival.

Authors:  Darshana D Rasalkar; Winnie C W Chu; Vincent Lee; Bhawan K Paunipagar; Frankie W T Cheng; Chi Kong Li
Journal:  Pediatr Radiol       Date:  2010-09-03

2.  Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.

Authors:  Tobie D Wolfe; Smitha Pankajavally Somanathan Pillai; Blake Eason Hildreth; Lisa G Lanigan; Chelsea K Martin; Jillian L Werbeck; Thomas J Rosol
Journal:  Clin Exp Metastasis       Date:  2011-03-04       Impact factor: 5.150

3.  Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.

Authors:  Elyssa M Rubin; Yi Guo; Khoa Tu; Jun Xie; Xiaolin Zi; Bang H Hoang
Journal:  Mol Cancer Ther       Date:  2010-03-02       Impact factor: 6.261

4.  Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.

Authors:  Shyh-Dar Li; Sumio Chono; Leaf Huang
Journal:  Mol Ther       Date:  2008-03-18       Impact factor: 11.454

5.  Cutaneous extraskeletal osteosarcoma on the scar of a previous bone graft.

Authors:  Sang Gon Park; Ji Young Song; In Guk Song; Min Sung Kim; Bong Seok Shin
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

6.  Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature.

Authors:  Robert Serpico; Jeffrey Brown; Alan Blank; Kevin Jones; R Lor Randall; John Groundland
Journal:  Case Rep Oncol       Date:  2021-03-31

7.  Parosteal Osteosarcoma with Pancreatic Metastasis and Multiple Relapses: A Case Report and Review of the Literature.

Authors:  Daniel Cirotski; Jyoti Panicker
Journal:  Case Rep Oncol       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.